scispace - formally typeset
N

Natalia Giltiay

Researcher at Cleveland Clinic

Publications -  8
Citations -  1037

Natalia Giltiay is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: B-cell activating factor & Immunology. The author has an hindex of 4, co-authored 5 publications receiving 924 citations.

Papers
More filters
Journal ArticleDOI

Astrocyte-Restricted Ablation of Interleukin-17-Induced Act1-Mediated Signaling Ameliorates Autoimmune Encephalomyelitis

TL;DR: Astroctyes are critical in IL-17-Act1-mediated leukocyte recruitment during autoimmune-induced inflammation of the CNS, and targeted Act1 deficiency in neuroectoderm-derived CNS-resident cells resulted in markedly reduced severity in EAE.
Journal ArticleDOI

Act1, a U-box E3 Ubiquitin Ligase for IL-17 Signaling

TL;DR: It is proposed that Act1 mediates IL- 17–induced signaling pathways through its E3 ubiquitin ligase activity and that TRAF6 is a critical substrate of Act1, which indicates the importance of protein ubiquitination in the IL-17–dependent inflammatory response.
Journal ArticleDOI

Deficiency of Act1, a critical modulator of B cell function, leads to development of Sjögren's syndrome.

TL;DR: It is demonstrated that mice deficient in Act1 developed systemic autoimmune disease with histological and serological features of human Sjögren's syndrome (SS), in association with systemic lupus erythematosus‐like nephritis.